Biotage Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:PQX1 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Jul 24Buy€49,878Scott CarrIndividual2,973€16.78

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PQX1?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders455,8540.569%
Private Companies13,590,64817%
General Public16,932,26221.2%
Institutions49,070,50861.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 71.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.9%
Gamma Biosciences Newco Limited
11,946,867€166.5m0%no data
7.95%
Carnegie Fonder AB
6,365,330€88.7m175%0.93%
5.84%
SEB Investment Management AB
4,675,806€65.2m0.71%0.13%
4.87%
Forsta AP-fonden
3,900,000€54.4m0%0.22%
4.76%
Invesco Ltd.
3,808,712€53.1m0%0.01%
4.25%
Handelsbanken Asset Management
3,400,219€47.4m0%0.07%
3.48%
Norges Bank Investment Management
2,787,400€38.8m0%no data
3.46%
Fourth Swedish National Pension Fund (AP4)
2,769,095€38.6m0%0.17%
3.27%
Swedbank Robur Fonder AB
2,616,783€36.5m0%0.03%
2.81%
Tredje AP-fonden
2,246,762€31.3m0%0.15%
2.76%
Capital Research and Management Company
2,207,932€30.8m1,040%no data
2.61%
The Vanguard Group, Inc.
2,086,000€29.1m-0.02%no data
2.05%
Gamma Biosciences Newco 2 Limited
1,643,781€22.9m0%no data
1.22%
Andra AP-fonden
972,839€13.6m0%0.08%
1.21%
BlackRock, Inc.
968,462€13.5m-1.83%no data
0.89%
Danske Capital Denmark
710,000€9.9m0%0.04%
0.78%
UBS Asset Management AG
621,539€8.7m-8.54%no data
0.77%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
615,805€8.6m0%0.32%
0.66%
Humle Kapitalförvaltning AB
529,280€7.4m0%1.65%
0.6%
Nordea Investment Management, AB
481,819€6.7m-0.16%no data
0.59%
Lansforsakringar Fondforvaltning AB
472,801€6.6m0%0.03%
0.56%
Catella Fondförvaltning AB
444,536€6.2m0%2.34%
0.53%
Montanaro Investment Managers Ltd.
427,300€6.0m0%0.33%
0.52%
Lonvia Capital
419,277€5.8m0%2.45%
0.52%
Storebrand Fonder AB,
412,873€5.8m0%0.02%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 11:00
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biotage AB (publ) is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Odysseas ManesiotisBerenberg
Marcus BellanderCarnegie Investment Bank AB